HKEX(HK:00388) Zhong Guo Jin Rong Xin Xi Wang·2025-10-14 05:33Core Viewpoint - Hong Kong Stock Exchange plans to launch the Hang Seng Biotechnology Index Futures to enhance its derivatives product ecosystem, focusing on the rapidly growing biotechnology sector [1] Group 1: Product Launch Details - The new futures contract will start trading on November 28, 2025, based on the Hang Seng Biotechnology Index, which tracks the performance of the 30 largest biotechnology, pharmaceutical, and medical device companies listed in Hong Kong that are eligible for Stock Connect trading [1] - The product aims to provide investors with precise risk management tools and complement existing biotechnology-related products and flagship stock index derivatives offered by the Hong Kong Stock Exchange [1] Group 2: Incentives and Fees - The first six months of trading for the new product will be exempt from the Securities and Futures Commission transaction fees [1] - The margin rate for the product will be announced in due course [1]